
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that binds to growth hormone secretagogue receptors. It stimulates sustained growth hormone release for up to 7 days, promoting muscle growth and fat metabolism.

Reported Benefits (Provisional)
Origin & History

CJC-1295 is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It is produced through peptide synthesis and is used for its potential to increase growth hormone levels.
Research Narrative (Provisional)
CJC-1295 has been studied in animal models and early human trials, showing potential for sustained growth hormone release. Further research is required.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Composed of a sequence of amino acids. - Administered via subcutaneous injection. - Long-acting due to its ability to bind to albumin.
Reported Mechanism (Provisional)
CJC-1295 binds to growth hormone secretagogue receptors (GHSR) in the anterior pituitary gland, triggering cyclic adenosine monophosphate (cAMP) signaling pathways. This stimulates somatotroph cells to release growth hormone in pulsatile patterns. The peptide's lysine modification allows it to bind to albumin, extending its half-life to approximately 6-8 days compared to natural GHRH's 7-minute half-life.
Clinical Narrative (Provisional)
Limited human studies exist for CJC-1295, with most research conducted on small cohorts of 10-20 participants. One study in healthy adults showed 2-10 fold increases in growth hormone levels lasting up to 6 days after injection. Animal studies demonstrate improved body composition with increased lean mass and reduced fat mass over 4-8 week periods. However, long-term safety data and large-scale clinical trials are lacking, limiting evidence quality.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







